SCOTTI, VIERI
 Distribuzione geografica
Continente #
NA - Nord America 3.800
EU - Europa 2.221
AS - Asia 1.907
SA - Sud America 213
AF - Africa 46
OC - Oceania 26
Continente sconosciuto - Info sul continente non disponibili 2
AN - Antartide 1
Totale 8.216
Nazione #
US - Stati Uniti d'America 3.744
RU - Federazione Russa 898
SG - Singapore 556
CN - Cina 512
IT - Italia 288
PL - Polonia 285
HK - Hong Kong 271
IE - Irlanda 195
BR - Brasile 166
KR - Corea 166
SE - Svezia 158
VN - Vietnam 146
DE - Germania 104
FR - Francia 98
IN - India 70
FI - Finlandia 69
GB - Regno Unito 59
JO - Giordania 55
CA - Canada 28
AU - Australia 25
ID - Indonesia 19
JP - Giappone 19
BD - Bangladesh 17
TR - Turchia 16
MX - Messico 15
NL - Olanda 15
AR - Argentina 14
IQ - Iraq 11
ZA - Sudafrica 11
ES - Italia 10
CI - Costa d'Avorio 9
UA - Ucraina 7
EC - Ecuador 6
UY - Uruguay 6
VE - Venezuela 6
AE - Emirati Arabi Uniti 5
BE - Belgio 5
BG - Bulgaria 5
CO - Colombia 5
CZ - Repubblica Ceca 5
DO - Repubblica Dominicana 5
EG - Egitto 5
KE - Kenya 5
LT - Lituania 5
NG - Nigeria 5
PK - Pakistan 5
UZ - Uzbekistan 5
AZ - Azerbaigian 4
PE - Perù 4
AT - Austria 3
CH - Svizzera 3
CR - Costa Rica 3
DZ - Algeria 3
HU - Ungheria 3
KG - Kirghizistan 3
KZ - Kazakistan 3
LB - Libano 3
MA - Marocco 3
TH - Thailandia 3
TW - Taiwan 3
AL - Albania 2
BJ - Benin 2
CL - Cile 2
GE - Georgia 2
GR - Grecia 2
IL - Israele 2
JM - Giamaica 2
MN - Mongolia 2
NP - Nepal 2
PS - Palestinian Territory 2
PY - Paraguay 2
SA - Arabia Saudita 2
AQ - Antartide 1
BO - Bolivia 1
BY - Bielorussia 1
EU - Europa 1
GY - Guiana 1
KY - Cayman, isole 1
LA - Repubblica Popolare Democratica del Laos 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
OM - Oman 1
PH - Filippine 1
SI - Slovenia 1
SN - Senegal 1
SV - El Salvador 1
TN - Tunisia 1
UG - Uganda 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 8.216
Città #
Santa Clara 709
Ashburn 487
Singapore 387
Fairfield 364
Warsaw 280
Hong Kong 240
Dublin 195
Chandler 184
Seoul 166
San Jose 158
Woodbridge 158
Seattle 144
Cambridge 129
Hefei 126
Wilmington 126
Houston 124
Beijing 111
Los Angeles 72
Florence 67
Lawrence 65
Altamura 64
Buffalo 60
Munich 55
Ho Chi Minh City 50
Princeton 45
Paris 44
New York 42
Hanoi 41
Moscow 41
Ann Arbor 38
Lauterbourg 37
The Dalles 34
Kent 33
Boston 31
Helsinki 28
Mumbai 27
Council Bluffs 26
Medford 24
Melbourne 24
Shanghai 22
Dallas 18
San Diego 18
Boardman 17
Milan 17
São Paulo 16
London 15
Rome 15
Tokyo 15
Bengaluru 13
Falls Church 13
Guangzhou 13
Redondo Beach 13
Clifton 12
Frankfurt am Main 12
Jacksonville 12
Jakarta 11
Stockholm 11
Turku 11
Montreal 10
Orem 10
Abidjan 9
Chicago 9
Manchester 9
Toronto 9
Phoenix 8
Baghdad 7
Poplar 7
Pune 7
San Francisco 7
Bari 6
Chennai 6
Dearborn 6
Haiphong 6
Hillsboro 6
Izmir 6
Johannesburg 6
Montevideo 6
Belo Horizonte 5
Brasília 5
Brussels 5
Des Moines 5
Sofia 5
Abuja 4
Ankara 4
Atlanta 4
Barcelona 4
Barnet 4
Dong Ket 4
Fortaleza 4
Kyiv 4
Lappeenranta 4
Tashkent 4
Tianjin 4
West Jordan 4
Yubileyny 4
Amman 3
Baku 3
Bexley 3
Bishkek 3
Biên Hòa 3
Totale 5.542
Nome #
Postmastectomy radiotherapy for locally advanced breast cancer receiving neoadjuvant chemotherapy. 291
Accelerated partial breast irradiation using intensity modulated radiotherapy versus whole breast irradiation: Health-related quality of life final analysis from the Florence phase 3 trial 257
Multiple cutaneous angiosarcomas after breast conserving surgery and bilateral adjuvant radiotherapy: an unusual case and review of the literature. 256
Use of an alfa-lipoic, Methylsulfonylmethane, Boswellia serrata and Bromelain dietary supplement (OPERA®) for aromatase inhibitors-related arthralgia management (AIA): a prospective phase II trial (NCT04161833) 234
Accelerated partial breast irradiation using intensity-modulated radiotherapy versus whole breast irradiation: 5-year survival analysis of a phase 3 randomised controlled trial 231
Aprepitant as prophylaxis of chemotherapy-induced nausea and vomiting in anthracyclines and cyclophosphamide-based regimen for adjuvant breast cancer 218
Use of an alpha lipoic, methylsulfonylmethane and bromelain dietary supplement (Opera®) for chemotherapy-induced peripheral neuropathy management, a prospective study 211
Accelerated partial breast irradiation using intensity-modulated radiotherapy technique compared to whole breast irradiation for patients aged 70 years or older: subgroup analysis from a randomized phase 3 trial 209
Accelerated Partial-Breast Irradiation Compared With Whole-Breast Irradiation for Early Breast Cancer: Long-Term Results of the Randomized Phase III APBI-IMRT-Florence Trial 202
Cardioprotective Strategy for Patients with Nonmetastatic Breast Cancer Who Are Receiving an Anthracycline-Based Chemotherapy: A Randomized Clinical Trial 199
Benefit of ablative versus palliative-only radiotherapy in combination with nivolumab in patients affected by metastatic kidney and lung cancer 195
Phase 2 placebo-controlled, single-blind trial to evaluate the impact of oral ibandronate on bone mineral density in osteopenic breast cancer patients receiving adjuvant aromatase inhibitors: 5-year results of the single-centre BONADIUV trial 192
External accelerated partial breast irradiation for ductal carcinoma in situ: long-term follow-up from a phase 3 randomized trial 190
91P * DEFINITIVE CONCOMITANT RADIOCHEMOTHERAPY (RCT) TREATMENT FOR LOCALLY ADVANCED (LA) NON SMALL CELL LUNG CANCER (NSCLC): EVALUATION OF HEMATOLOGICAL AND ESOPHAGEAL TOXICITY IN THE RADIATION ONCOLOGY DEPARTMENT OF UNIVERSITY OF FLORENCE EXPERIENCE 190
Accelerated Partial Breast Irradiation with IMRT: New Technical Approach and Interim Analysis of Acute Toxicity in a Phase III Randomized Clinical Trial. 189
Ribociclib plus letrozole and concomitant palliative radiotherapy for metastatic breast cancer 188
Impact of COVID-19 on patient–doctor interaction in a complex radiation therapy facility 187
Adjuvant trastuzumab in breast cancer: experience from the University of Florence. 183
Doxorubicin and cyclophosphamideversus cyclophosphamide, methotrexate, and 5-fluorouracil as adjuvantchemotherapy in breast cancer. 180
Predictive factors for additional non-sentinel lymph node involvement in breast cancer patients with one positive sentinel node 180
76P THE IMPACT OF A BREATHING-CONTROL SYSTEM ON TARGET MARGINS AND NORMAL TISSUE SPARING IN THE TREATMENT OF LUNG CANCER: ANALYSIS OF 12 CASES AT RADIOTHERAPY UNIT OF FLORENCE UNIVERSITY 179
Pembrolizumab for First-Line Treatment of Advanced Non-Small-Cell Lung Cancer: Analysis of Prognostic Factors of Outcomes 178
Application of helical tomotherapy for the treatment of a right atrium angiosarcoma: A case report 177
Quitting Smoking At or Around Diagnosis Improves the Overall Survival of Lung Cancer Patients: A Systematic Review and Meta-Analysis 171
Safety of eribulin mesylate and concomitant radiotherapy for metastatic breast cancer: a single-center experience 171
Lobectomy vs Stereotactic Ablative Radiotherapy in NSCLC: a multicentric series in four centers 166
Impact of age on cytotoxic-induced ovarian failure in breast cancer treated with adjuvant chemotherapy and triptorelin 166
Impact of COVID-19 on workload burden of a complex radiotherapy facility 166
Predictive factors for tolerance to taxane based chemotherapy in older adults affected by metastatic prostate cancer (ANCHISES-NCT05471427): A prospective observational trial including patients with metastatic hormone sensitive and castrate resistant prostate cancer treated with taxane chemotherapy 164
Immunotherapy in association with stereotactic radiotherapy for non-small cell lung cancer brain metastases: results from a multicentric retrospective study on behalf of AIRO 164
The impact of patient preference in the treatment algorithm for recurrent/metastatic head and neck squamous cell carcinoma 160
Prognostic role of human epidermal growth factor receptor 2 status in premenopausal early breast cancer treated with adjuvant tamoxifen. 159
Isolated chest wall implantation of non-small cell lung cancer after fine-needle aspiration: a case report and review of the literature. 158
The impact of young age on breast cancer outcome 153
Neoadjuvant oxaliplatin and 5-fluorouracil with concurrent radiotherapy in patients with locally advanced rectal cancer: a singleinstitution experience. 150
Clinical utility of Next Generation Sequencing of plasma cell-free DNA for the molecular profiling of patients with NSCLC at diagnosis and disease progression 148
Impact of a breathing-control system on target margins and normal-tissue sparing in the treatment of lung cancer: experience at the radiotherapy unit of Florence University. 147
Update chemotherapy schedule in the treatment of lung cancer 144
Correction to: Impact of COVID-19 on patient–doctor interaction in a complex radiation therapy facility (Supportive Care in Cancer, (2021), 29, 6, (2931-2937), 10.1007/s00520-020-05793-3) 134
Impact of sentinel node tumor burden on outcome of invasive breast cancer patients. 132
Post-operative radiotherapy in N2 non-small cell lung cancer: a retrospective analysis of 175 patients. 125
Vinorelbine-based chemo-radiotherapy in non-small cell lung cancer. 122
Recent Advances and Current Challenges in Stereotactic Body Radiotherapy for Ultra-Central Lung Tumors 118
Radiotherapy timing in the treatment of limited-stage small cell lung cancer: the impact of thoracic and brain irradiation on survival. 112
Is there a worthwhile value in personalizing radiation therapy for breast cancer patients? Time for a new paradigm in the older adult population 112
Circulating Tumor Cell-Free DNA as Prognostic Biomarker in Non-Small Cell Lung Cancer Patients Undergoing Immunotherapy: The CORELAB Experience 104
Postoperative radiotherapyin stage I/II endometrial cancer: retrospective analysis of 883 patients treated at the University of Florence. 103
The role of postoperative radiotherapy for thymomas: a multicentric retrospective evaluation from three Italian centers and review of the literature 85
Desensitization Protocol for Cemiplimab-Related Infusion Reaction in Cutaneous Squamous Cell Carcinoma: A Case Report and Literature Review 29
Retrospective evaluation of the "neutrophil-lymphocyte ratio" (NLR) in patients affected by locally advanced unresectable stage III NSCLC treated with Durvalumab within the Italian expanded access program (EAP): results of the neutrality trial 6
Totale 8.285
Categoria #
all - tutte 24.652
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.652


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202114 0 0 0 0 0 0 0 0 0 0 0 14
2021/2022304 4 15 20 15 17 20 11 17 18 12 58 97
2022/2023839 67 199 34 37 59 149 103 49 109 5 15 13
2023/2024422 12 32 46 14 24 70 24 107 6 28 44 15
2024/20252.402 76 225 146 400 643 251 50 160 131 94 98 128
2025/20262.625 352 392 269 216 337 105 339 135 195 196 89 0
Totale 8.285